Martí Duran-Ferrer

@ContraCancerEs postdoc @idibaps @hospitalclinic🦀visiting @ICR_London @CEC_ICR🧬cancer evolution, epigenomics📈lymphoid tumors🩸aging⏱️Mallorquí🏋️‍♀️🎸🍣🏔️

[Martí Duran-Ferrer @Marti_DF]

Extremely happy to recive this award! Thanks to all the people involved and to @Fundpfizer_ES to promote spanish science of young researchers. Hope this can help patients soon! @pfizer_spain @idibaps @hospitalclinic @BEpigenomics

[IDIBAPS @idibaps]

Martí Duran-Ferrer receives the @Fundpfizer_ES Award for Scientific Innovation for Young Researchers

👉https://t.co/93PP8rVZMr

[PharmaExpertise @PharmaExpertise]

Nueva metodología epigenética reconstruye evolución cáncer y anticipa la progresión clínica
https://t.co/hYSxrXWpVy
UNIVERSAL para todo tipo de cánceres!
@noticias_cuatro @idibaps @cnag_eu @Marti_DF @ERC_Research @ICR_London @trevoragraham @CalumGabbutt @irianovo

[Martí Duran-Ferrer @Marti_DF]

@rmassonix Merci Ramon! Una abraçada!

[Martí Duran-Ferrer @Marti_DF]

🚨Our new study is out. The evolutionary history of tumors is written in the epigenome!
Check this wonderful thread by my partner in crime!👉🏻

[Calum Gabbutt @CalumGabbutt]

This was a massively collaborative project and it was a pleasure to work with such amazing researchers, but particular thanks to @Marti_DF, @BEpigenomics and @trevoragraham. (7/7)

[Hospital Clínic @hospitalclinic]

🔬 Un equipo internacional liderado por #CLÍNIC-@idibaps e @ICR_LondonCR_London ha desarrollado una metodología epigenética que permite reconstruir la evolución del #cáncer y anticipar su progresión clínica.

🧬 El método se basa en los cambios en la metilación del ADN para descifrar el origen y la evolución del cáncer y se aplicó a 2.000 muestras de pacientes con distintos tipos de lecuemias y linfomas.

El estudio lo publica hoy la revista @Nature 👉 https://t.co/lwjHsYI1rB

[Hospital Clínic @hospitalclinic]

🔬 An international team led by #CLÍNIC-@idibaps and @ICR_London has developed an epigenetic methodology that enables the reconstruction of cancer evolution and helps anticipate its clinical progression.

🧬 The method is based on changes in DNA methylation to decipher the origin and evolution of cancer, and it was applied to 2,000 samples from patients with different types of leukemias and lymphomas.

The findings are published today in @Nature 👉 https://t.co/9Lw32aDvaF

[Martí Duran-Ferrer @Marti_DF]

@TCeliaTerrassa @Cancer_Cell Enhorabona una altra vegada Toni!🙌🏻

[Alfredo Rivas-Delgado @arivasdelgado]

Excited to share our latest publication on the genomics of Testicular Large B-Cell Lymphoma — @Hemasphere_EHA @clopezgonz85 @SilviaBea1 - https://t.co/1gtjbjFNbm 🧵👇🏼 #Lymphoma #Genomics #TLBCL #DLBCL #PCNSL #Hematology #CancerResearch

[Toni Celia-Terrassa @TCeliaTerrassa]

FPI PhD position open in our group!
Project topic: Breast cancer metastasis & immunotherapy research.
Deadline 31st October.

[Francisco Martínez-Jiménez @fran_mj88]

We’re looking for a motivated PhD student to join our team at VHIO for an exciting computational immuno-oncology project. Want to be part of our young, dynamic team? Check out the position and apply! 💻🧬 #PhD #CompImmunoGenomics https://t.co/TAC1uKoM8v

[Martí Duran-Ferrer @Marti_DF]

@PolonenPetri @CMullighan @Nature Congrats Petri for the hard work! 🎉

[Jon Strefford @JonStrefford]

Check out our new review article of the genomic and epigenetic landscape of splenic marginal zone lymphoma, which was published online today. Well done to @a_mirandari for all your hard work bring this review together.

https://t.co/8f0Pm6view

[Julio Delgado @JulioDelgadoHem]

Today, at TLH, we summarise a decade of hard work. We wish to thank all colleagues, patients and relatives, who helped us during this amazing journey.
https://t.co/CIzVqbLH3m

[Lluis Montoliu @LluisMontoliu]

Hoy 26 de junio @Nature publica dos artículos de Patrick Hsu con un nuevo sistema de edición genética basado en el elemento móvil IS110 que usa un ARN dual, capaz de unirse a ADN origen y destino y propiciar inserciones, deleciones e inversiones limpias.
https://t.co/X94YQkwcZz

[Trevor Graham @trevoragraham]

New #vacancy for a Lab Manager to support the 11 labs across our Division of Molecular Pathology @ICR_London, which includes our Centre for Evolution and Cancer @CEC_ICR. Details here: https://t.co/QCZe4FvdFA @JonesLabICR @kamilkranc @PaedCancerEvol @BezziLab_ICR @HuangLabICR

[Claudia García Cobarro @Claudia_GarCb]

Nos vemos el 3,4 y 5 de julio en las playas de San Pedro del Pinatar participando en esta iniciativa preciosa!!! No dudéis en consultar los talleres y actividades que el equipo de @umudivulga está organizando 💙☺️🤗🌊 feliz de colaborar en esta ocasión por el Mar Menor 🦩🥰🙏🏻

[Martí Duran-Ferrer @Marti_DF]

@JonStrefford @a_mirandari Very good presentation indeed @a_mirandari! 👌🏻😊

[Martí Duran-Ferrer @Marti_DF]

This is today! Come and join us to discuss some cool science! 😁👇🏻

[Martí Duran-Ferrer @Marti_DF]

Heading Madrid for #EHA2024!🩸Tomorrow I’ll present our work @CalumGabbutt @trevoragraham @BEpigenomics on tracking cancer evolution with DNA meth on lymphoid tumors, at scale, with clinical implications!👉🏻 https://t.co/ZaWgAZp6LK
@EHA_Hematology @young_eha @ContraCancerEs

[Alba Maiques-Diaz @alba_maiques]

If u are into DNA methylation, clonal cell evolution and mind-blowing bioinfo analysis, mark this talk on your agenda for tomorrow's #EHA2024 👇

@BEpigenomics @idibaps @young_eha

[Martí Duran-Ferrer @Marti_DF]

Heading Madrid for #EHA2024!🩸Tomorrow I’ll present our work @CalumGabbutt @trevoragraham @BEpigenomics on tracking cancer evolution with DNA meth on lymphoid tumors, at scale, with clinical implications!👉🏻 https://t.co/ZaWgAZp6LK
@EHA_Hematology @young_eha @ContraCancerEs

[Asociación Española Contra el Cáncer Zaragoza @ContraCancerZGZ]

Encantados con el compromiso mostrado por Calatayud y su comarca al acoger una nueva edición del Encuentro de Jóvenes Investigadores que reúne estos días a más de 40 personas trabajando por y para el futuro de la investigación en cáncer 💪💚